Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
7,845,682
-
Share change
-
+449,245
-
Total reported value
-
$133,762,985
-
Price per share
-
$17.05
-
Number of holders
-
47
-
Value change
-
+$4,141,737
-
Number of buys
-
29
-
Number of sells
-
23
Institutional Holders of NEURODERM LTD - ORD SHS as of Q4 2015
As of 31 Dec 2015,
NEURODERM LTD - ORD SHS was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,845,682 shares.
The largest 10 holders included
SCOPIA CAPITAL MANAGEMENT LP, Redmile Group, LLC, venBio Select Advisor LLC, ACUTA CAPITAL PARTNERS, LLC, BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, BlackRock Fund Advisors, Foresite Capital Management III, LLC, ACADIAN ASSET MANAGEMENT LLC, and SENZAR ASSET MANAGEMENT, LLC.
This page lists
47
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.